Related references
Note: Only part of the references are listed.B cells are associated with survival and immunotherapy response in sarcoma
Florent Petitprez et al.
NATURE (2020)
B cells and tertiary lymphoid structures promote immunotherapy response
Beth A. Helmink et al.
NATURE (2020)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Long-Term Survivors of Pancreatic Cancer: A California Population-Based Study
Adel Kardosh et al.
PANCREAS (2018)
Effect of Hospital Volume on In-hospital Morbidity and Mortality Following Pancreatic Surgery in Germany
Christian Krautz et al.
ANNALS OF SURGERY (2018)
IL35-Producing B Cells Promote the Development of Pancreatic Neoplasia
Yuliya Pylayeva-Gupta et al.
CANCER DISCOVERY (2016)
Bruton Tyrosine Kinase-Dependent Immune Cell Cross-talk Drives Pancreas Cancer
Andrew J. Gunderson et al.
CANCER DISCOVERY (2016)
Hif1a Deletion Reveals Pro-Neoplastic Function of B Cells in Pancreatic Neoplasia
Kyoung Eun Lee et al.
CANCER DISCOVERY (2016)
Spatial distribution of B cells predicts prognosis in human pancreatic adenocarcinoma
Giovanni Francesco Castino et al.
ONCOIMMUNOLOGY (2016)
Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancers
Marie-Caroline Dieu-Nosjean et al.
IMMUNOLOGICAL REVIEWS (2016)
Long-term survival in patients with pancreatic ductal adenocarcinoma
Alexander P. Stark et al.
SURGERY (2016)
Prognostic role and correlation of CA9, CD31, CD68 and CD20 with the desmoplastic stroma in pancreatic ductal adenocarcinoma
Angela Diana et al.
ONCOTARGET (2016)
Intratumoral tertiary lymphoid organ is a favourable prognosticator in patients with pancreatic cancer
N. Hiraoka et al.
BRITISH JOURNAL OF CANCER (2015)
Patient-Derived Tumor Xenografts Are Susceptible to Formation of Human Lymphocytic Tumors
Gennadiy Bondarenko et al.
NEOPLASIA (2015)
The immune network in pancreatic cancer development and progression
S. M. Woermann et al.
ONCOGENE (2014)
The presence of tumour-associated lymphocytes confers a good prognosis in pancreatic ductal adenocarcinoma: an immunohistochemical study of tissue microarrays
Nilanjana Tewari et al.
BMC CANCER (2013)
Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer
Y. Ino et al.
BRITISH JOURNAL OF CANCER (2013)
B cells and their mediators as targets for therapy in solid tumors
Andrew J. Gunderson et al.
EXPERIMENTAL CELL RESEARCH (2013)
Differential pattern and prognostic significance of CD4+, FOXP3+ and IL-17+ tumor infiltrating lymphocytes in ductal and lobular breast cancers
Raoul Droeser et al.
BMC CANCER (2012)
A CD44-/CD24+ phenotype is a poor prognostic marker in early invasive breast cancer
Mohamed A. H. Ahmed et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
CD24 shows early upregulation and nuclear expression but is not a prognostic marker in colorectal cancer
M. A. H. Ahmed et al.
JOURNAL OF CLINICAL PATHOLOGY (2009)
PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription
Rajani Kanteti et al.
LABORATORY INVESTIGATION (2009)
Syndecan-1 expression - A novel prognostic marker in pancreatic cancer
A Juuti et al.
ONCOLOGY (2005)
Share Paper
